Cargando…

Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide

Current therapies for childhood T-cell acute lymphoblastic leukemia have increased survival rates to above 85% in developed countries. Unfortunately, some patients fail to respond to therapy and many suffer from serious side effects, highlighting the need to investigate other agents to treat this di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ede, Benjamin C., Asmaro, Rafal R, Moppett, John P., Diamanti, Paraskevi, Blair, Allison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119138/ https://www.ncbi.nlm.nih.gov/pubmed/29773592 http://dx.doi.org/10.3324/haematol.2017.186700

Ejemplares similares

Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia
por: Cox, Charlotte V., et al.
Publicado: (2016)

Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors
por: Diamanti, Paraskevi, et al.
Publicado: (2020)

Non-toxic polymer nanovectors for improved delivery of dexamethasone
por: Ede, Benjamin C., et al.
Publicado: (2021)

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019)

TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia
por: Chu, Ming, et al.
Publicado: (2016)

NET1 Enhances Proliferation and Chemoresistance in Acute Lymphoblastic Leukemia Cells
por: Sun, Hongbo, et al.
Publicado: (2019)

The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia
por: Meyer, Lauren K., et al.
Publicado: (2019)

Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
por: Mogensen, Pernille Rudebeck, et al.
Publicado: (2020)

The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021)

3114 Investigating the therapeutic potential of parthenolide in the treatment of hematopoietic neoplasms in dogs
por: Schlein, Lisa J, et al.
Publicado: (2019)

Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells in vitro
por: Kouhpaikar, Hamideh, et al.
Publicado: (2020)

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
por: Ariës, Ingrid M., et al.
Publicado: (2018)

Obesity in patients with acute lymphoblastic leukemia in childhood
por: Iughetti, Lorenzo, et al.
Publicado: (2012)

Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation
por: Kong, Seom Gim, et al.
Publicado: (2014)

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019)

Synthesized evidence for childhood acute lymphoblastic leukemia
por: Onyije, Felix M., et al.
Publicado: (2023)

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
por: O’Connor, David, et al.
Publicado: (2018)

Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche
por: Ma, Chao, et al.
Publicado: (2020)

In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
por: Zong, Hongliang, et al.
Publicado: (2015)

Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
por: Darwish, Noureldien H. E., et al.
Publicado: (2019)

Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways
por: Petit, C., et al.
Publicado: (2016)

Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia
por: Schirmer, M, et al.
Publicado: (2016)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
por: Koo, Hong Hoe
Publicado: (2011)

Cytogenetic Instability in Childhood Acute Lymphoblastic Leukemia Survivors
por: Brassesco, María Sol, et al.
Publicado: (2011)

Compliance with a protocol for acute lymphoblastic leukemia in childhood
por: de Oliveira, Benigna Maria, et al.
Publicado: (2011)

Prognostic significance of leukopenia in childhood acute lymphoblastic leukemia
por: SHIOZAWA, YUSUKE, et al.
Publicado: (2014)

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
por: Swaminathan, Srividya, et al.
Publicado: (2015)

Insights into the prenatal origin of childhood acute lymphoblastic leukemia
por: Hein, Daniel, et al.
Publicado: (2020)

Obesity and Sarcopenia in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Malhotra, Payal, et al.
Publicado: (2021)

Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023)

Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
por: Zou, Jie, et al.
Publicado: (2013)

CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance
por: Ebadi, Maryam, et al.
Publicado: (2021)

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
por: Bhattarai, Kashi Raj, et al.
Publicado: (2023)

Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia
por: Ng, O H, et al.
Publicado: (2014)

Childhood B-acute lymphoblastic leukemia: a genetic update
por: Woo, Jennifer S, et al.
Publicado: (2014)

A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
por: Pui, CH, et al.
Publicado: (2014)

Flow Cytometric DNA Index and Karyotype in Childhood Lymphoblastic Leukemia
por: Forestier, Erik, et al.
Publicado: (1998)

The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
por: Pei, Jen-Sheng, et al.
Publicado: (2018)

Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors
por: Kızılocak, Hande, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_opuq250hh1ll69aiqs64nlmt78